The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

AC1NSFN3     (2S,3S)-3-[[(2E)-2-(2- azaniumyl-1,3...

Synonyms: DB00355, AC1Q29OK
This record was replaced with 5459211.
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Azactam


High impact information on Azactam


Chemical compound and disease context of Azactam


Biological context of Azactam


Anatomical context of Azactam


Associations of Azactam with other chemical compounds


Gene context of Azactam


Analytical, diagnostic and therapeutic context of Azactam


  1. Empiric antibiotic use--aztreonam as a model. Levin, S. Am. J. Med. (1990) [Pubmed]
  2. Aztreonam plus clindamycin as therapy for pelvic infections in women. Pastorek, J.G., Cole, C., Aldridge, K.E., Crapanzano, J.C. Am. J. Med. (1985) [Pubmed]
  3. Binding of monobactams to penicillin-binding proteins of Escherichia coli and Staphylococcus aureus: relation to antibacterial activity. Georgopapadakou, N.H., Smith, S.A., Cimarusti, C.M., Sykes, R.B. Antimicrob. Agents Chemother. (1983) [Pubmed]
  4. In vitro activity of carumonam (Ro 17-2301; AMA-1080) versus enteropathogenic and nonfermentative gram-negative rods and Legionella pneumophila. Hohl, P., von Graevenitz, A., Zollinger-Iten, J. Antimicrob. Agents Chemother. (1988) [Pubmed]
  5. In vitro activity of a group of broad-spectrum cephalosporins and other beta-lactam antibiotics against Chlamydia trachomatis. Hammerschlag, M.R., Gleyzer, A. Antimicrob. Agents Chemother. (1983) [Pubmed]
  6. Refined crystal structure of beta-lactamase from Citrobacter freundii indicates a mechanism for beta-lactam hydrolysis. Oefner, C., D'Arcy, A., Daly, J.J., Gubernator, K., Charnas, R.L., Heinze, I., Hubschwerlen, C., Winkler, F.K. Nature (1990) [Pubmed]
  7. Crystallographic mapping of beta-lactams bound to a D-alanyl-D-alanine peptidase target enzyme. Kelly, J.A., Knox, J.R., Zhao, H., Frère, J.M., Ghaysen, J.M. J. Mol. Biol. (1989) [Pubmed]
  8. Water-assisted alkaline hydrolysis of monobactams: a theoretical study. Díaz, N., Suárez, D., Sordo, T.L., Tuñón, I., Silla, E. Chemistry (Weinheim an der Bergstrasse, Germany) (2002) [Pubmed]
  9. Optimum therapy for acute pelvic inflammatory disease. Dodson, M.G. Drugs (1990) [Pubmed]
  10. In vitro antimicrobial activity of tigemonam, a new orally administered monobactam. Fuchs, P.C., Jones, R.N., Barry, A.L. Antimicrob. Agents Chemother. (1988) [Pubmed]
  11. In vivo evaluation of tigemonam, a novel oral monobactam. Clark, J.M., Olsen, S.J., Weinberg, D.S., Dalvi, M., Whitney, R.R., Bonner, D.P., Sykes, R.B. Antimicrob. Agents Chemother. (1987) [Pubmed]
  12. Effect of aztreonam in combination with azlocillin or piperacillin on Pseudomonas aeruginosa. Wu, D.H., Baltch, A.L., Smith, R.P., Conley, P.E. Antimicrob. Agents Chemother. (1984) [Pubmed]
  13. MM 42842, a new member of the monobactam family produced by Pseudomonas cocovenenans. I. Identification of the producing organism. Gwynn, M.N., Box, S.J., Brown, A.G., Gilpin, M.L. J. Antibiot. (1988) [Pubmed]
  14. SQ 28,332, a new monobactam produced by a Flexibacter sp. Taxonomy, fermentation, isolation, structure determination and biological properties. Singh, P.D., Johnson, J.H., Ward, P.C., Wells, J.S., Trejo, W.H., Sykes, R.B. J. Antibiot. (1983) [Pubmed]
  15. In vitro activity of carumonam (RO 17-2301) and twelve other antimicrobials against clinical isolates of Pseudomonas aeruginosa. Vurma-Rapp, U., Kayser, F.H. Eur. J. Clin. Microbiol. (1986) [Pubmed]
  16. Multiple-dose pharmacokinetics of the monobactam azthreonam (SQ 26,776) in healthy subjects. Swabb, E.A., Sugerman, A.A., McKinstry, D.N. Antimicrob. Agents Chemother. (1983) [Pubmed]
  17. Immunology of the monobactam aztreonam. Adkinson, N.F., Swabb, E.A., Sugerman, A.A. Antimicrob. Agents Chemother. (1984) [Pubmed]
  18. Oral bioavailability of the monobactam aztreonam (SQ 26,776) in healthy subjects. Swabb, E.A., Sugerman, A.A., Stern, M. Antimicrob. Agents Chemother. (1983) [Pubmed]
  19. Monobactam antibiotics in subinhibitory concentrations enhance opsonophagocytosis and serum bacteriolysis in certain Escherichia coli strains. Veringa, E., Box, A., Rozenberg-Arska, M., Verhoef, J. Drugs under experimental and clinical research. (1988) [Pubmed]
  20. Aztreonam versus colistin-neomycin for selective decontamination of the digestive tract in patients undergoing bone marrow transplantation: a randomized study. Bosi, A., Fanci, R., Pecile, P., Guidi, S., Saccardi, R., Vannucchi, A.M., Longo, G., Donnini, E., Orsi, A., Rossi-Ferrini, P. Journal of chemotherapy (Florence, Italy) (1992) [Pubmed]
  21. Aztreonam in the treatment of urinary tract infections: a multicenter trial. Martelli, A., Cortecchia, V., Ventriglia, L. Chemotherapy. (1989) [Pubmed]
  22. Effects of sub-minimal inhibitory concentrations of antimicrobial agents on the cell surface of Klebsiella pneumoniae and phagocytic killing activity. Nomura, S., Murata, K., Nagayama, A. Journal of chemotherapy (Florence, Italy) (1995) [Pubmed]
  23. beta-Lactam antibiotic modulation of murine neutrophil cytokinesis. Kenny, M.T., Balistreri, F.J., Torney, H.L. Immunopharmacology and immunotoxicology. (1992) [Pubmed]
  24. Influence of growth rate and nutrient limitation on monobactam production and peptidoglycan synthesis in Pseudomonas aeruginosa. Allison, D.G., Nolan, R.D. J. Basic Microbiol. (1994) [Pubmed]
  25. Effects of granulocyte colony stimulating factor and monobactam antibiotics (Aztreonam) on neutrophil functions in sepsis. Goya, T., Torisu, M., Doi, F., Yoshida, T. Clin. Immunol. Immunopathol. (1993) [Pubmed]
  26. In vitro evaluation of tigemonam, a novel oral monobactam. Tanaka, S.K., Summerill, R.A., Minassian, B.F., Bush, K., Visnic, D.A., Bonner, D.P., Sykes, R.B. Antimicrob. Agents Chemother. (1987) [Pubmed]
  27. Pharmacokinetics and tissue penetration of carumonam, a new synthetic monobactam. McNulty, C.A., Garden, G.M., Ashby, J., Wise, R. Antimicrob. Agents Chemother. (1985) [Pubmed]
  28. Forecasting cephalosporin and monobactam antibiotic half-lives in humans from data collected in laboratory animals. Mordenti, J. Antimicrob. Agents Chemother. (1985) [Pubmed]
  29. Disposition of [14C]aztreonam in rats, dogs, and monkeys. Kripalani, K.J., Singhvi, S.M., Weinstein, S.H., Everett, D.W., Bathala, M.S., Dean, A.V., Ita, C.E., Lawrence, L., Meeker, F.S., Shaw, J.M. Antimicrob. Agents Chemother. (1984) [Pubmed]
  30. Effect of conalbumin on the activity of Syn 2190, a 1,5 dihydroxy-4-pyridon monobactam inhibitor of AmpC beta-lactamases. Babini, G.S., Livermore, D.M. J. Antimicrob. Chemother. (2000) [Pubmed]
  31. In vitro activity and beta-lactamase stability of a new monobactam, B0-1165. Neu, H.C., Chin, N.X. Antimicrob. Agents Chemother. (1987) [Pubmed]
  32. Microbiology, safety, and pharmacokinetics of aztreonam lysinate for inhalation in patients with cystic fibrosis. Gibson, R.L., Retsch-Bogart, G.Z., Oermann, C., Milla, C., Pilewski, J., Daines, C., Ahrens, R., Leon, K., Cohen, M., McNamara, S., Callahan, T.L., Markus, R., Burns, J.L. Pediatr. Pulmonol. (2006) [Pubmed]
  33. Aztreonam. Childs, S.J., Bodey, G.P. Pharmacotherapy (1986) [Pubmed]
  34. Synthesis and antibacterial activity of C-4 thio- and dithiocarbamate monobactam derivatives. Cascio, G., Lorenzi, L., Caglio, D., Manghisi, E., Arcamone, F., Guanti, G., Satta, G., Morandotti, G., Sperning, R. Farmaco (1996) [Pubmed]
  35. Review of the clinical pharmacology of the monobactam antibiotic aztreonam. Swabb, E.A. Am. J. Med. (1985) [Pubmed]
  36. Metabolism and pharmacokinetics of aztreonam in healthy subjects. Swabb, E.A., Singhvi, S.M., Leitz, M.A., Frantz, M., Sugerman, A. Antimicrob. Agents Chemother. (1983) [Pubmed]
  37. Role of aztreonam in lower respiratory tract infections. Cook, J.L. Urology (1988) [Pubmed]
WikiGenes - Universities